TGFBR2 and neoplasm: And emerging evidence indicated that metastatic breast tumor cells release abundant TβRII-positive sEVs and stimulated transforming growth factor-β (TGF-β)/SMAD activation in adjacent pre-malignant tumor cells and remote recipient such as CD8+ T cells.